ACCPOTCinactive
ACCELERATED PHARMA, INC.
Healthcare·Oncology
OncologyNeurologyImmunology
ACCELERATED PHARMA, INC. (ACCP): 1 pipeline candidate · 2 clinical trials. Updated within the last hour.
6.7/10
BioSniper Score
2-factor signal · derived from public data
Cash RunwayN/A
N/A
Financial Health10.0
D/E -1.00 · 0% dilution
Pipeline MaturityN/A
N/A
Pipeline Breadth3.3
1 candidate
Catalyst MomentumN/A
N/A
Insider SignalN/A
N/A
A transparent, data-derived signal for ACCELERATED PHARMA, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
—
Quarterly Burn
$43K
Runway
—
Revenue
—
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| picoplatin | — |
2 clinical trials
Get the full picture on ACCELERATED PHARMA, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.